𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cortical glucose metabolism in parkinson's and alzheimer's disease

✍ Scribed by R. F. Peppard; W. R. W. Martin; C. M. Clark; G. D. Carr; P. L. McGeer; D. B. Calne


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
852 KB
Volume
27
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Characteristic regional patterns of decreased cerebral glucose metabolism (rCMRG) have been described in a variety of neurodegenerative conditions associated with dementia. The present study was undertaken to determine whether the metabolic pattern in Parkinson's disease is altered by the presence of impaired cognitive function. Glucose metabolism was measured with positron emission tomography in 6 patients with Parkinson's disease and dementia (PDD), 8 patients with Parkinson's disease and normal cognition (PD), and 6 patients with Alzheimer's disease (AD). All AD patients subsequently had the diagnosis proven neuropathologically at autopsy. Correlation coefficients of the metabolic rates across 32 regions of interest were calculated between each pair of patients. Q‐component analysis of the correlation matrix showed that the AD and PD groups formed two distinct clusters and that the PDD group had a metabolic pattern which was similar to that of the AD group. Comparison of standardized rCMRG values showed that the PDD group differed from the PD group in having significantly lower relative rCMRG in the left perirolandic and bilateral angular gyrus regions. There were no significant differences between the PDD and AD groups. These results suggest a similar pattern of cortical dysfunction in both Alzheimer's disease and in Parkinson's disease/dementia.


πŸ“œ SIMILAR VOLUMES


Glucose metabolic rate and progression o
✍ Benjamin V. Siegel Jr.; Monte S. Buchsbaum; Arnold Starr; Richard C. Mohs; Dirce πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 742 KB

## Abstract Thirty‐eight patients with mild to moderate Alzheimer's disease (AD) underwent a neuropsychological test battery and 18‐fluoro‐2‐deoxyglucose (FDG) positron emission tomography (PET) before beginning and at the end of a randomized double‐blind study of an experimental treatment. Twelve

Apathy and cortical atrophy in Alzheimer
✍ C. Tunnard; D. Whitehead; C. Hurt; LO. Wahlund; P. Mecocci; M. Tsolaki; B. Vella πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 126 KB πŸ‘ 1 views

## Abstract ## Objectives Apathy has been reported as the most prevalent behavioural symptom experienced in Alzheimer's disease (AD), associated with greater functional decline and caregiver distress. The aim of the current study was to investigate structural correlates of apathy in AD using magne